Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Democrats and Republicans were more ‘reasonable’ than in 2023) are striking
The big date to watch for equities may be May 2.
“Buying healthcare, staples and portfolio convexity is the best way to handle the ‘summer heat,’ which, similar to 2011’s debt ceiling, will begin in May.” That convexity strategy for Evercore consists of option calls — right to buy an asset at a set price by a specific date — on the SPDR S&P Biotech ETF (XBI) and puts — rights to sell — on Invesco QQQ Trust Series I (QQQ).
As for those so-called “pause rebounders,” the Evercore team has screened the Russell 1000 (RUI) for healthcare, biotech and consumer staple stocks which have lagged behind their sector median performance, but have 2023 earnings per share growth above the sector median. "
One of the potential outperforming stock is like to be INCY
Technically:
Cycle Sniper H4 headed North
Clocing Above 76$ resistance will trigger the bullish price action
Target will be: 78, 82, 86 and 90 $
Good Luck'
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Democrats and Republicans were more ‘reasonable’ than in 2023) are striking
The big date to watch for equities may be May 2.
“Buying healthcare, staples and portfolio convexity is the best way to handle the ‘summer heat,’ which, similar to 2011’s debt ceiling, will begin in May.” That convexity strategy for Evercore consists of option calls — right to buy an asset at a set price by a specific date — on the SPDR S&P Biotech ETF (XBI) and puts — rights to sell — on Invesco QQQ Trust Series I (QQQ).
As for those so-called “pause rebounders,” the Evercore team has screened the Russell 1000 (RUI) for healthcare, biotech and consumer staple stocks which have lagged behind their sector median performance, but have 2023 earnings per share growth above the sector median. "
One of the potential outperforming stock is like to be INCY
Technically:
Cycle Sniper H4 headed North
Clocing Above 76$ resistance will trigger the bullish price action
Target will be: 78, 82, 86 and 90 $
Good Luck'
For alerts,charts,special reports,news and singals over 15.000 + instruments contact us via pm or our free Discord: discord.gg/Ku9kzfq
Link to services and products: linktr.ee/chartreaderpro
Link to services and products: linktr.ee/chartreaderpro
